Home » California Dialogue for Action » Continuing Medical Education

CME Information
 This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of California, San Diego School of Medicine and the California Dialogue on Cancer, the Cancer Research and Prevention Foundation, and the Centers for Disease Control and Prevention. The University of California, San Diego School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of California, San Diego School of Medicine designates this educational activity for a maximum of 7.5 Category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

  1. AAFP: Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
  2. AAPA: Accepts Category 1 AMA PRA credit from organizations accredited by the ACCME to grant Category 1 credit.
  3. AOA: This program is approved for 7.5 AOA Category 2-A CME credits by the AOA CCME.
  4. BBS: Course meets the qualifications for 7.5 hours of continuing education credit for MFTs and/or LCSWs as required by the California Board of Behavioral Sciences. (UCSD Provider Number PCE 683)
  5. BRN:Under the California BRN guidelines, this course is accredited for up to 7.5 hours of nursing credit (#CMA - Cat. 1).

CME certificates will be distributed at the conclusion of the conference.

Conference Learning Objectives

After attending California's Dialogue for Action, participants should be able to:

  1. Identify strategies to reduce disparities in colorectal cancer prevention, screening, diagnosis, and treatment among underserved* populations in California.
  2. Identify strategies to increase colorectal cancer screening rates of California adults according to accepted guidelines**; those 50 years and older as well as younger persons at increased risk, especially among underserved* populations.
  3. Describe current methods and best practices of colorectal cancer prevention, screening, and early detection.
  4. Understand the role of advocacy in reducing disparities in colorectal cancer screening.

*"Underserved" includes but is not limited to persons who are uninsured, underinsured, of low socioeconomic status, not literate, or lack education.

**These are the guidelines currently recommended by the U.S. Preventative Services Task Force, American Cancer Society, National Institute of Health, and Centers for Disease Control.